Establishment and characterization of a new mantle cell lymphoma cell line, Mino.
about
P1343
Development and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture CollectionDetailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma CellsComprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation SequencingAntiproliferative and proapoptotic activity of GUT-70 mediated through potent inhibition of Hsp90 in mantle cell lymphomaFTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma.Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma.Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma.Lenalidomide inhibits lymphangiogenesis in preclinical models of mantle cell lymphomaSmall Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models.Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease.Establishment and characterization of therapy-resistant mantle cell lymphoma cell lines derived from different tissue sites.PRDM1 is required for mantle cell lymphoma response to bortezomib.HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis.Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.CCMCL1: a new model of aggressive mantle cell lymphoma.Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma.Modulation of p73 isoforms expression induces anti-proliferative and pro-apoptotic activity in mantle cell lymphoma independent of p53 status.Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma.
P2860
Q27913808-6D1FAFAA-9F85-47A0-9EEF-6880275683A4Q28547322-50A38CF7-6E50-47AC-A98E-C00523C4CB7FQ28547976-7107F47B-2267-4418-9404-7B38B3D602FBQ30498194-DA8722FE-2815-4D4A-AD1A-3EFEC42AE420Q30535265-1687CFC7-9496-462B-A8CF-C1798FCF6352Q33706095-EDC35EF7-2C76-44FA-BDA9-5FABAC81526CQ33798463-FBD24725-4738-4E4C-B48E-91025937CC82Q34997715-1E537F09-DB87-4019-A2D1-22E521946903Q37273485-9DB66AD5-FD87-4F87-9D4D-40D0C28960F4Q37626685-BF3EDB09-89D8-4ECB-B052-8D47F2B3A9E7Q38743296-2BF22E9C-9988-4EFB-AAE9-1FD4EC0C8CCEQ39017105-2EFBC484-67F9-46DB-A73E-3CF88458B87EQ39352014-AED9730B-D014-48F1-B22B-840DEE3FA627Q39695887-C7B92CE2-1FBD-4901-B917-48B25ABA7A14Q39753901-8BF2D9AE-D75C-49AD-9702-4065D509869AQ40557863-36121868-6E52-4D15-BB93-6D75DFED0F34Q42553373-39B5FAC4-C84E-49C8-889A-8F136D46620FQ46118117-164335E3-8717-4ED7-BE1C-11F071174124Q47624912-F97EB206-D444-4353-B80B-3ABDB50037A4Q51682819-1AF80BE1-01B4-4050-B9BD-4C43D619E31E
P2860
Establishment and characterization of a new mantle cell lymphoma cell line, Mino.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Establishment and characterization of a new mantle cell lymphoma cell line, Mino.
@en
type
label
Establishment and characterization of a new mantle cell lymphoma cell line, Mino.
@en
prefLabel
Establishment and characterization of a new mantle cell lymphoma cell line, Mino.
@en
P2093
P1433
P1476
Establishment and characterization of a new mantle cell lymphoma cell line, Mino.
@en
P2093
McDonnell TJ
Medeiros LJ
O'Connor SL
P304
P356
10.1016/S0145-2126(02)00013-9
P4510
P577
2002-09-01T00:00:00Z